137 related articles for article (PubMed ID: 15732250)
1. [Impact of oncologic therapeutic concepts 2004].
Zielinski CC
Acta Med Austriaca; 2004; 31(4):139-43. PubMed ID: 15732250
[TBL] [Abstract][Full Text] [Related]
2. [Oncogenes--"reckless drivers" on signal pathways controlling cell division].
Johansen T; Bjørkøy G
Tidsskr Nor Laegeforen; 1998 May; 118(12):1880-5. PubMed ID: 9638058
[TBL] [Abstract][Full Text] [Related]
3. [Value of inhibition of signal transduction and epigenetic therapy concepts in cancer therapy].
Tabernero J; Kaye S
Onkologie; 2005 Oct; 28 Suppl 4():43-7. PubMed ID: 16285040
[No Abstract] [Full Text] [Related]
4. Key cancer cell signal transduction pathways as therapeutic targets.
Bianco R; Melisi D; Ciardiello F; Tortora G
Eur J Cancer; 2006 Feb; 42(3):290-4. PubMed ID: 16376541
[TBL] [Abstract][Full Text] [Related]
5. Cytodifferentiation by retinoids, a novel therapeutic option in oncology: rational combinations with other therapeutic agents.
Garattini E; Gianni' M; Terao M
Vitam Horm; 2007; 75():301-54. PubMed ID: 17368321
[TBL] [Abstract][Full Text] [Related]
6. [Significance of molecular genetics in oncology].
Parreira L
Acta Med Port; 1991 Dec; 4 Suppl 1():28S-34S. PubMed ID: 1805529
[TBL] [Abstract][Full Text] [Related]
7. Rational targeting of Notch signaling in cancer.
Rizzo P; Osipo C; Foreman K; Golde T; Osborne B; Miele L
Oncogene; 2008 Sep; 27(38):5124-31. PubMed ID: 18758481
[TBL] [Abstract][Full Text] [Related]
8. Anti-apoptotic proteins-targets for chemosensitization of tumor cells and cancer treatment.
Kostanová-Poliaková D; Sabová L
Neoplasma; 2005; 52(6):441-9. PubMed ID: 16284687
[TBL] [Abstract][Full Text] [Related]
9. Targeting loss-of-function mutations in tumor-suppressor genes as a strategy for development of cancer therapeutic agents.
Wang H; Han H; Mousses S; Von Hoff DD
Semin Oncol; 2006 Aug; 33(4):513-20. PubMed ID: 16890805
[TBL] [Abstract][Full Text] [Related]
10. Cellular effects of cancer chemotherapy administration.
Moran P
J Intraven Nurs; 2000; 23(1):44-51. PubMed ID: 11013533
[TBL] [Abstract][Full Text] [Related]
11. Oncogene addiction versus oncogene amnesia: perhaps more than just a bad habit?
Felsher DW
Cancer Res; 2008 May; 68(9):3081-6; discussion 3086. PubMed ID: 18451131
[TBL] [Abstract][Full Text] [Related]
12. Modulation of apoptosis signaling for cancer therapy.
Fulda S; Debatin KM
Arch Immunol Ther Exp (Warsz); 2006; 54(3):173-5. PubMed ID: 16652217
[TBL] [Abstract][Full Text] [Related]
13. New molecular mechanisms of action of camptothecin-type drugs.
Legarza K; Yang LX
Anticancer Res; 2006; 26(5A):3301-5. PubMed ID: 17094444
[TBL] [Abstract][Full Text] [Related]
14. Effects of fibres on cell proliferation, cell activation and gene expression.
Driscoll KE
IARC Sci Publ; 1996; (140):73-96. PubMed ID: 9101318
[No Abstract] [Full Text] [Related]
15. Antibodies as oncogenes: a hypothesis.
Admon A; Shoshan SH
Med Hypotheses; 2006; 67(3):471-3. PubMed ID: 16632230
[TBL] [Abstract][Full Text] [Related]
16. Rapamycin: an anti-cancer immunosuppressant?
Law BK
Crit Rev Oncol Hematol; 2005 Oct; 56(1):47-60. PubMed ID: 16039868
[TBL] [Abstract][Full Text] [Related]
17. Intracellular signal transduction pathway proteins as targets for cancer therapy.
Adjei AA; Hidalgo M
J Clin Oncol; 2005 Aug; 23(23):5386-403. PubMed ID: 15983388
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanisms of signal transduction: epidermal growth factor receptor family, vascular endothelial growth factor family, Kit, platelet-derived growth factor receptor, Ras.
Erman M
J BUON; 2007 Sep; 12 Suppl 1():S83-94. PubMed ID: 17935283
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
[TBL] [Abstract][Full Text] [Related]
20. Developmental biology and oncology: two sides to the same coin? Sixth International Conference on the Differentiation of Normal and Neoplastic Cells sponsored by the International Society of Differentiation and the Canadian Society for Cellular and Molecular Biology, Vancouver, B.C., Canada, July 29-August 2, 1990.
Sutherland H; Dougherty G; Dedhar S
New Biol; 1990 Nov; 2(11):970-3. PubMed ID: 1966264
[No Abstract] [Full Text] [Related]
[Next] [New Search]
